000 03307nam a22004337a 4500
001 MT 2023 0009
003 PILC
005 20241031083133.0
008 230526b xxu||||| |||| 00| 0 eng d
040 _beng
_cFEU-NRMF MEDICAL LIBRARY
_erda
041 _aenglish
050 _aMT 2023 0009
245 _aA Systematic review of laboratory parameters predictive of long haul COVID-19 /
_cAliyah B. Aurellana, Camille Serg R. De Guzman, Tom Cedrick G. Estrella, Cara Angela S. Nayve, Miryltrix A. Pedroche, Angela Mae S. Sarangaya, Erica Mae F. Shabado, Jan Naomi C. Tomes, John Robert A. Villalon, Angel Mikaela S. Villarama, Jane Louise S. Villareal and Ma. Kathlene Angela V. Villostas.
260 _aFairview, Quezon City:
_bSchool of Medical Technology, FEU-NRMF,
_c2023.
300 _a55 pages:
_billustrations, tables;
_c28 cm.
336 _2rdacontent
_atext
337 _2rdamedia
_aunmedaited
338 _2rdacarrier
_avolume
504 _aIncludes appendices and bibliographical references.
520 _aAbstract: The aftermath of COVID-19 infection resulted in a syndrome now called long-haul COVID-19. It is a condition wherein the clinical signs and symptoms persist for an extended period. Persistent symptoms manifested by patients are fatigue, cough, dyspnea, headache, brain fog, anosmia, and dysgeusia. But, symptoms experienced by patients may vary, thus making diagnosing the syndrome complex. A total of 14 studies published between 2020 to 2022 gathered from ScienceDirect, ResearchGate and PubMed were included in the systematic review. The researchers utilized PRISMA guidelines to systematically review all possible laboratory parameters used to predict long-haul COVID-19. Results showed that C-reactive Protein, D-dimer, Erythrocyte Sedimentation Rate, Interleukin-2, Interleukin-6, Lymphocyte, Total Antibodies, Troponin-I, Interferon-β, Interferon-λ1 and Ferritin are associated with the development and persistence of symptoms manifested by long-haul patients and can be used as the parameter for diagnosis. Meanwhile, Lactate dehydrogenase (LDH), Alanine transaminase (ALT), Aspartate aminotransferase (AST), Total Bilirubin, Creatinine, Lipocalin-2, Matrix Metalloproteinases-7, and Hepatocyte growth factor showed probable association with long-haul COVID-19. However, it still requires further validation on extensive studies before it can be used as a parameter for the long haul.
521 _aTHMT
650 _aCOVID-19
650 _along-haul COVID-19
650 _alaboratory parameters
700 _aAurellana, Aliyah B.
_eauthor
700 _aDe Guzman, Camille Serg R.
_eauthor
700 _aEstrella, Tom Cedrick G.
_eauthor
700 _aNayve, Cara Angela S.
_eauthor
700 _aPedroche, Miryltrix A.
_eauthor
700 _aSarangaya, Angela Mae S.
_eauthor
700 _aShabado, Erica Mae F.
_eauthor
700 _aTomes, Jan Naomi C.
_eauthor
700 _aVillalon, John Robert A.
_eauthor
700 _aVillarama, Angel Mikaela S.
_eauthor
700 _aVillareal, Jane Louise S.
_eauthor
700 _aVillostas, Ma. Kathlene Angela V.
_eauthor
856 _21
_30
_qpdf
_uhttps://library.feu-nrmf.ph/cgi-bin/koha/opac-retrieve-file.pl?id=512b4da8bf5c5f76fa6b28e44dd9abcc
_yClick here for FULL TEXT
_1ALL
942 _2lcc
_cRU
999 _c12534
_d12534